| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
POS-019 A CASE OF CFHR5 NEPHROPATHY IN A PATIENT WITHOUT CYPRIOT ANCESTRY
|
Zakharova, E.
|
|
|
|
6S |
p. S445-S446
|
artikel
|
| 2 |
POS-037 ACTIVATION OF THE ALTERNATIVE PATHWAY OF COMPLEMENT FAVORS THROMBUS FORMATION ON MICROVASCULAR ENDOTHELIAL CELLS IN ACUTE HEMOLYTIC UREMIC SYNDROME INDUCED BY SHIGA-LIKE-TOXIN PRODUCING E.COLI (STEC-HUS)
|
Galbusera, M.
|
|
|
|
6S |
p. S453-S454
|
artikel
|
| 3 |
POS-038 ALTERNATIVE COMPLEMENT PATHWAY INHIBITION WITH IPTACOPAN TO ARREST DISEASE PROGRESSION IN C3 GLOMERULOPATHY (APPEAR-C3G): A PHASE 3 STUDY
|
Smith, R.
|
|
|
|
6S |
p. S454-S455
|
artikel
|
| 4 |
POS-001 A NOVEL CFHR5 COPY NUMBER VARIATION ASSOCIATED WITH POST-PARTUM ATYPICAL HUS SUPERIMPOSED TO HELLP SYNDROME
|
Piras, R.
|
|
|
|
6S |
p. S437
|
artikel
|
| 5 |
POS-035 A PHASE 3 STUDY TO SUPPORT IPTACOPAN REGISTRATION IN ATYPICAL HEMOLYTIC UREMIC SYNDROME (aHUS): OVERVIEW OF APPELHUS STUDY DESIGN CONSIDERATIONS
|
Kavanagh, D.
|
|
|
|
6S |
p. S452-S453
|
artikel
|
| 6 |
POS-017 A POPULATION PERSPECTIVE OF NEPHRITIC FACTORS AS SYSTEMIC DRIVERS OF COMPLEMENT DYSREGULATION IN C3 GLOMERULOPATHY
|
HAUER, J.
|
|
|
|
6S |
p. S444
|
artikel
|
| 7 |
POS-020 ARTIFICIAL INTELLIGENCE ASSISTED QUANTIFICATION OF COMPLEMENT CONVERTASES IN GLOMERULONEPHRITIS
|
WIECH, T.
|
|
|
|
6S |
p. S446
|
artikel
|
| 8 |
POS-004 ATYPICAL HEMOLYTIC UREMIC SYNDROME IN YOUNG FEMALE: CASE FOR DISCUSSION
|
Elrewaihby, W.A.E.S.
|
|
|
|
6S |
p. S438
|
artikel
|
| 9 |
POS-039 ATYPICAL RENAL RECOVERY FROM ATYPICAL HEMOLYTIC UREMIC SYNDROME
|
COVELLA, B.
|
|
|
|
6S |
p. S455
|
artikel
|
| 10 |
POS-036 A YOUNG FEMALE WITH RENAL CORTICAL NECROSIS TREATED WITH INTRAVENOUS IMMUNOGLOBULIN IN A RESOURCE POOR SETTING: CASE REPORT
|
MONIKA, K.
|
|
|
|
6S |
p. S453
|
artikel
|
| 11 |
POS-040 BCX9930, AN ORAL FACTOR D INHIBITOR IN DEVELOPMENT FOR THE TREATMENT OF COMPLEMENT-MEDIATED KIDNEY DISEASES, INHIBITS COMPLEMENT ALTERNATIVE PATHWAY ACTIVITY IN HEALTHY SUBJECTS
|
Chen, X.
|
|
|
|
6S |
p. S455-S456
|
artikel
|
| 12 |
POS-041 BCX9930, AN ORAL FACTOR D INHIBITOR, SUPPRESSES COMPLEMENT ALTERNATIVE PATHWAY ACTIVITY IN PATIENTS WITH COMPLEMENT 3 GLOMERULOPATHY
|
Chen, X.
|
|
|
|
6S |
p. S456
|
artikel
|
| 13 |
POS-030 CARBAMYLATED HEMOGLOBIN AND HEMODIALYSIS ADEQUACY
|
HASSAN, A.
|
|
|
|
6S |
p. S451
|
artikel
|
| 14 |
POS-021 C4 COMPLEMENT DEFICIENCY AND TYPE III CRYOGLOBUINEMIA IN A PATIENT WITH MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS
|
ALEXANDRU, S.
|
|
|
|
6S |
p. S446-S447
|
artikel
|
| 15 |
POS-042 C3d-Directed Factor H Targeting Delivers Potent and Durable Complement Inhibition and Disease-Modifying Efficacy In Kidney and Skin Without Inhibiting Systemic Complement
|
Liu, F.
|
|
|
|
6S |
p. S456-S457
|
artikel
|
| 16 |
POS-002 CHARACTERIZATION OF MONOCLONAL ANTIBODIES AGAINST DIFFERENT FORMS OF THE A SUBUNIT OF SHIGA TOXIN 2a
|
KELLNEROVÁ, S.
|
|
|
|
6S |
p. S437
|
artikel
|
| 17 |
POS-005 CLINICODEMOGRAPHIC PROFILE OF HEMODIALYSIS DEPENDENT PATIENTS DIAGNOSED AS ATYPICAL HEMOLYTIC UREMIC SYNDROME AND COMPLEMENT RELATED GLOMERULOPATHY
|
Balwani, M.
|
|
|
|
6S |
p. S438-S439
|
artikel
|
| 18 |
POS-023 CLINICOPATHOLOGICAL CHARACTERISTICS OF C3 DOMINANT GLOMERULOPATHIES: A RETROSPECTIVE STUDY FROM A LOW-RESOURCE SETTING
|
Wijayaratne, D.
|
|
|
|
6S |
p. S447-S448
|
artikel
|
| 19 |
POS-022 CLINICO-PATHOLOGICAL PROFILE AND OUTCOMES OF CHILDREN WITH C3G IN RESOURCE LIMITED SETTING
|
Vasudevan, A.
|
|
|
|
6S |
p. S447
|
artikel
|
| 20 |
POS-006 COMPLEMENT ASSOCIATED RENAL DISEASE: MORE PREVALENT THAN THOUGHT
|
Balwani, M.
|
|
|
|
6S |
p. S439
|
artikel
|
| 21 |
POS-024 COMPLEMENT FACTOR I VARIANTS IN ATYPICAL HEMOLYTIC UREMIC SYNDROME AND C3 GLOMERULOPATHY
|
ZHANG, Y.
|
|
|
|
6S |
p. S448
|
artikel
|
| 22 |
POS-025 COMPLEMENT MEDIATED MONOCLONAL GAMMOPATHY OF RENAL SIGNIFICANCE (MGRS)
|
SEPPÄLÄ, M.
|
|
|
|
6S |
p. S448-S449
|
artikel
|
| 23 |
POS-007 COMPLEMENT RELATED GENETIC MUTATIONS IN ASYMPTOMATIC KIDNEY DONORS: A SERIES OF THREE RARE CASES
|
Balwani, M.
|
|
|
|
6S |
p. S439-S440
|
artikel
|
| 24 |
POS-026 DEPOSIT DENSE DISEASE (DDD), MONOCLONAL GAMMOPATHY in a 20 y.o. WOMAN USING KETOPROPHEN
|
Sidoti, A.
|
|
|
|
6S |
p. S449
|
artikel
|
| 25 |
POS-031 Developing and validating a Risk Score Model for prediction of Acute Kidney Injury (AKI) in Non-ICU Hospitalized Patients
|
Elrewaihby, W.A.E.S.
|
|
|
|
6S |
p. S451
|
artikel
|
| 26 |
POS-043 DEVELOPMENT AND MANIFESTATION OF CHRONIC KIDNEY DISEASE IN GENERALIZED CONGENITAL LIPODYSTROPHY: REPORT OF A CHILEAN CASE AND REVIEW OF THE LITERATURE
|
Tiscornia, C.
|
|
|
|
6S |
p. S457
|
artikel
|
| 27 |
POS-044 ECULIZUMAB INTERRUPTION IN KIDNEY TRANSPLANT RECIPIENTS WITH ATYPICAL HEMOLYTIC UREMIC SYNDROME: ANALYSIS OF A BRAZILIAN SHORTAGE
|
NETO, M.
|
|
|
|
6S |
p. S457
|
artikel
|
| 28 |
POS-045 Evaluating BCX9930, an Oral Factor D Inhibitor for Treatment of Complement-Mediated Kidney Disease: A Proof-of-Concept Study (RENEW)
|
Nester, C.
|
|
|
|
6S |
p. S457-S458
|
artikel
|
| 29 |
POS-008 EXTRARENAL MANIFESTATIONS OF ATYPICAL HEMOLYTIC UREMIC SYNDROME: CARDIAC AND LUNG INVOLVEMENT
|
Ivanova, E.
|
|
|
|
6S |
p. S440
|
artikel
|
| 30 |
POS-032 Human PLA2R-antibodies induce membranous nephropathy in minipigs and activate complement
|
Stahl, R.
|
|
|
|
6S |
p. S451-S452
|
artikel
|
| 31 |
POS-033 HYPOCOMPLEMENTEMIC ANCA-ASSOCIATED VASCULITIS: CASE REPORT
|
DIAZ GARCIA, J.D.
|
|
|
|
6S |
p. S452
|
artikel
|
| 32 |
POS-009 IgA NEPHROPATHY AS A PRECIPITATING FACTOR FOR ATYPICAL HEMOLYTIC UREMIC SYNDROME: A REPORT OF THREE CASES
|
Balwani, M.
|
|
|
|
6S |
p. S440-S441
|
artikel
|
| 33 |
POS-046 KIDNEY TRANSPLANTATION IN aHUS IN A RESOURCE POOR SETTING- ARE WE ALLOWED TO GAMBLE IN THE ECULIZUMAB ERA?
|
ŠIMUNOV, B.
|
|
|
|
6S |
p. S458
|
artikel
|
| 34 |
POS-034 LAPAROSCOPIC VERSUS OPEN-SURGERY CATHETER PLACEMENT IN PERITONEAL DIALYSIS PATIENTS: A META-ANALYSIS OF OUTCOMES
|
ABDIJALIL, G.
|
|
|
|
6S |
p. S452
|
artikel
|
| 35 |
POS-027 OUTCOME OF KIDNEY GRAFTS TRANSPLANTED FOR C3 GLOMERULOPATHY AND MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS
|
Halfon, M.
|
|
|
|
6S |
p. S449-S450
|
artikel
|
| 36 |
POS-010 PERINUCLEAR ANTINEUTROPHIL CYTOPLASMIC ANTIBODY VASCULITIS AS A TRIGGER ATYPICAL HEMOLYTIC UREMIC SYNDROME: A RARE CASE
|
Balwani, M.
|
|
|
|
6S |
p. S441
|
artikel
|
| 37 |
POS-018 PHASE CONTRAST MAGNETIC RESONANCE IMAGING TO ASSESS RENAL PERFUSION IN PATIENTS WITH C3 GLOMERULOPATHY OR IMMUNE-COMPLEX MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS
|
VILLA, G.
|
|
|
|
6S |
p. S444-S445
|
artikel
|
| 38 |
POS-048 PHASE 3, RANDOMIZED, MULTICENTER STUDY TO EVALUATE THE EFFICACY AND SAFETY OF PEGCETACOPLAN IN TREATMENT OF C3G OR IC-MPGN
|
Remuzzi, G.
|
|
|
|
6S |
p. S459
|
artikel
|
| 39 |
POS-047 PHASE 2 STUDY TO EVALUATE EFFICACY AND SAFETY OF PEGCETACOPLAN IN THE TREATMENT OF PATIENTS WITH POSTTRANSPLANT RECURRENCE OF C3G OR IC MPGN
|
Palakow, N.
|
|
|
|
6S |
p. S458-S459
|
artikel
|
| 40 |
POS-011 PRIMARY ATYPICAL HEMOLYTIC-UREMIC SYNDROME ASSOCIATED WITH COVID-19: A BRIEF REVIEW
|
MALGAJ VREČKO, M.
|
|
|
|
6S |
p. S441-S442
|
artikel
|
| 41 |
POS-049 PROPHYLACTIC ECULIZUMAB PREVENTS POST-TRANSPLANT ATYPICAL HEMOLYTIC UREMIC SYNDROME RECURRENCE: A SINGLE CENTER COHORT
|
Garbellini, A.
|
|
|
|
6S |
p. S459
|
artikel
|
| 42 |
POS-028 Rare genetic alterations in patients with C3 glomerulopathy-something to ponder upon
|
KUMAR, A.
|
|
|
|
6S |
p. S450
|
artikel
|
| 43 |
POS-029 RARE VARIANTS IN COMPLEMENT GENES AND OUTCOMES OF C3 GLOMERULOPATHY AND IMMUNOGLOBULIN-MEDIATED MPGN
|
MEULEMAN, M.S.
|
|
|
|
6S |
p. S450-S451
|
artikel
|
| 44 |
POS-012 SCLERODERMA RENAL CRISIS AS A TRIGGER FOR ATYPICAL HEMOLYTIC UREMIC SYNDROME: A RARE CASE
|
Balwani, M.
|
|
|
|
6S |
p. S442
|
artikel
|
| 45 |
POS-050 THE PATIENT JOURNEY FOR IMMUNOGLOBULIN A NEPHROPATHY: DIAGNOSTIC DELAY AND CHANGE IN KIDNEY FUNCTION FROM FIRST CLINICAL SIGN
|
Perkins, R.
|
|
|
|
6S |
p. S459-S460
|
artikel
|
| 46 |
POS-003 The three C-terminal domains of FHR1 influence complement activation and FHR1 cooperation with other complement regulators
|
PERIE, L.
|
|
|
|
6S |
p. S437-S438
|
artikel
|
| 47 |
POS-013 THROMBOTIC MICROANGIOPATHY AFTER COVID-19: LACK OF EVIDENCE OF COMPLEMENT ACTIVATION? A CASE REPORT
|
Vu, A.
|
|
|
|
6S |
p. S442
|
artikel
|
| 48 |
POS-051 TST004, a humanized IgG4 anti-MASP2 antibody, demonstrates potent in vitro/in vivo inhibitory activities on MASP2 complement pathway and good safety profiles in non-human primate (NHP)
|
SUN, D.
|
|
|
|
6S |
p. S460
|
artikel
|
| 49 |
POS-052 TWO PHASE III TRIALS EVALUATING CROVALIMAB IN PATIENTS WITH ATYPICAL HAEMOLYTIC URAEMIC SYNDROME (aHUS): COMMUTE-a and COMMUTE-p
|
Sheerin, N.
|
|
|
|
6S |
p. S460-S461
|
artikel
|
| 50 |
POS-053 Type I Beta Interferon induced thrombotic microangiopathy – Could the alternative pathway of the complement be implicated?
|
TAGHAVI, M.
|
|
|
|
6S |
p. S461
|
artikel
|
| 51 |
POS-014 USE OF ECULIZUMAB FOR ATYPICAL HEMOLYTIC UREMIC SYNDROME AND SECONDARY THROMBOTIC MICROANGIOPATHY: CASE SERIES
|
VITKAUSKAITĖ, M.
|
|
|
|
6S |
p. S442-S443
|
artikel
|
| 52 |
POS-054 UTILITY OF PLASMA EXCHANGE AND RITUXIMAB IN PERIOPERATIVE PERIOD AMONG PATIENTS OF COMPLEMENT-ASSOCIATED RENAL DYSFUNCTION UNDERGOING TRANSPLANTATION: REPORT OF THREE RARE CASES
|
Balwani, M.
|
|
|
|
6S |
p. S462
|
artikel
|
| 53 |
POS-055 UTILITY OF RITUXIMAB IN THE TREATMENT OF ANTIBODY MEDIATED ATYPICAL HAEMOLYTIC UREMIC SYNDROME
|
RAVI, R.
|
|
|
|
6S |
p. S462
|
artikel
|
| 54 |
POS-015 VARIED PRESENTATIONS OF ATYPICAL HEMOLYTIC UREMIC SYNDROME AND COMPLEMENT RELATED GLOMERULOPATHY IN CKD-ND POPULATION
|
Balwani, M.
|
|
|
|
6S |
p. S443
|
artikel
|
| 55 |
POS-016 YOUNG GIRL WITH ATYPICAL HEMOLYTIC UREMIC SYNDROME: A CASE REPORT
|
Elrewaihby, W.A.E.S.
|
|
|
|
6S |
p. S443-S444
|
artikel
|
| 56 |
The ISN Frontiers Meeting “Complement-Related Kidney Diseases: Classification, Genetics, and Treatment” Abstracts Bergamo, Italy June 23–25, 2022
|
|
|
|
|
6S |
p. A1
|
artikel
|
Tijdschrift beschrijving